Unveiling factors shaping distress levels over 2.5 years of enduring adversity.

Unveiling factors shaping distress levels over 2.5 years of enduring adversity.

Publication date: Jul 30, 2024

In the face of global adversities such as pandemics, military conflicts, and socio-political unrest, the resilience and well-being of populations can be severely tested. This study examines the fluctuating levels of distress within the Israeli population over a period of 2. 5 years, encompassing events like the COVID-19 pandemic and various socio-political and security crises. Utilizing a quasi-longitudinal design, data were collected at thirteen time-points, mirroring the demographic makeup of the Israeli Jewish adult population. Measures of psychological distress, societal and individual resilience, hope, morale, and perceived danger were assessed, alongside demographic variables. Statistical analyses included ANOVA and stepwise regression models. Distress levels displayed significant oscillations in response to adverse events. High distress was noted during the latter stages of the study, particularly following a major security incident on October 7, 2023. The regression analyses identified morale and perceived danger as consistent important associations with distress, with individual resilience also inversely related across all time points. The study reveals the dynamic nature of psychological distress in relation to a range of adversities. Morale emerged as a key buffer against distress, whereas perceived danger was a significant stressor, especially during acute- existential threats. These findings have important implications for mental health interventions and policy-making aimed at fostering resilience and mitigating distress in crisis conditions.

Open Access PDF

Concepts Keywords
5years Adversities
Global Associations
Jewish Disasters
Models Distress levels
Pandemic Emergencies

Semantics

Type Source Name
disease VO population
disease MESH COVID-19 pandemic
disease VO time
disease MESH psychological distress
disease VO ANOVA
drug DRUGBANK Coenzyme M
disease MESH Emergencies
disease VO effective
disease IDO process
disease IDO entity
disease VO organization
disease MESH uncertainty
drug DRUGBANK Iron
disease MESH morbidity
disease MESH violence
disease MESH infection
disease IDO country
disease VO vaccination
disease MESH suicidal ideation
disease MESH loneliness
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH marital status
disease VO frequency
disease VO Rho

Original Article

(Visited 2 times, 1 visits today)